In 2026, the pharmaceutical industry has undergone a radical transformation, as Digital Twins for Drug Discovery slash the time and cost of clinical trials. In 2026, researchers are using virtual patient cohorts to predict drug efficacy and adverse reactions with 85% accuracy before human testing even begins. This 2026 breakthrough is particularly vital for Orphan Drugs and Rare Diseases, where...